Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	Cytokine activity	18 months	measured by staining assays
Primary	T-cell Proliferation	18 months	measured by flow cytometry
Primary	Serum Levels	18 months	measured by staining assays
Primary	Tissue Infiltration	18 months	measured by staining assays
Primary	Secondary antigen Spread	18 months	measured by flow cytometry
Secondary	Radiographic progression-free survival	18 months
Secondary	PSA Response Rate	18 months
Secondary	Time to PSA progression	18 months
Secondary	Measure CTCs and characterize response	18 months
Secondary	Objective tumor response rate	18 months
Secondary	Number of Adverse Events	18 months

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02793765/registered